Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Closing Thoughts on Metastatic Breast Cancers
July 01, 2020 – 
The panel provides key takeaways for the treatment of metastatic breast cancers.
Who Identifies and Manages Progressive Chronic Fibrosing ILD?
June 29, 2020 – 
The panel details which health care professionals are involved in diagnosing and managing chronic fibrosing interstitial lung disease with progressive phenotype.
How Is Chronic Fibrosing ILD With Progressive Phenotype Diagnosed?
June 29, 2020 – 
Shared insight on the diagnosis of chronic fibrosing interstitial lung disease with progressive phenotype.
Patient, Advocate, and Payer on Value-Based Care for mBC
June 26, 2020 – 
Kelli Davis, METAvivor patient advocate and co-founder of the Northwest Arkansas Metsquerade, and Steven Peskin, MD, MBA, FACP, executive medical director at Horizon Blue Cross Blue Shield of New Jersey, provide their perspectives as a patient and patient advocate and payer of value-based care.
Assessing the Value of Personalized Treatment in mBC
June 24, 2020 – 
Assessing the value of personalized medicine from a payer and provider perspective and the importance of evidence-based data.
Considerations for NGS Testing in mTNBC
June 24, 2020 – 
Exploring the use of NGS testing in metastatic TNBC and a payer perspective on use of the appropriate companion diagnostic.
Chronic Fibrosing ILD: Presentation and Comorbidities
June 22, 2020 – 
Multifaceted discussion on the presentation of chronic fibrosing interstitial lung disease with progressive phenotype and potential comorbidities.
Patient Journey and Development of Metastatic Breast Cancer
June 22, 2020 – 
Kelli Davis, METAvivor Patient Advocate and Co-Founder of the Northwest Arkansas Metsquerade, provides an insight into her journey as a patient with metastatic breast cancer and as a patient advocate.
Signs of Chronic Fibrosing ILD With Progressive Phenotype
June 22, 2020 – 
Considerations for symptoms that are tied to chronic fibrosing interstitial lung disease with progressive phenotype.
Chronic Fibrosing ILD With Progressive Phenotype
June 17, 2020 – 
Experts review chronic fibrosing interstitial lung disease with progressive phenotype and its different forms of manifestation.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.